Between January and April 2018, Russia dispatched 100.9 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 6.4% lower than that of the same period of 2017. In physical terms, Russia produced 1.32 bln units of pharmaceuticals, which is 10.8% lower than that of the same period of 2017.

The performance in April is nowhere near outstanding, with a 22.5% fall in monetary terms, which is the worst dynamics over the past 40 months. The dynamics in physical terms, while not as bad as in March, are still negative, -13.2%.

Between January and March 2018, Russia imported 13.4 bln RUB worth of veterinary products, with 7.3 bln RUB for feed supplements (9.4% increase in monetary terms), 5.6 bln RUB for veterinary drugs (12% increase), and 0.48 bln RUB for veterinary APIs (20% increase.)

Between January and March 2018, Russia imported 22 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 28% higher than that of the same period of 2017. In physical terms, Russia imported 2680 tons of APIs, which is 11% higher than that of the same period of 2017.Q1 2018 2018, the import of technical APIs shows an 8% and 4.4% fall in physical and monetary terms, respectively. 97% was imported from China, 2.7% from India, and the rest from the Czech Republic.

Between January and March 2018, Russia imported 113.9 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 0.2% higher than that of the same period of 2017, and 24.4 bln RUB worth of in-bulk pharmaceuticals, which is in monetary terms 18.5% higher than that of the same period of 2017. In total, the dynamics are 3%.